Fluctuating plasma phosphorus level by changes in dietary phosphorus intake induces endothelial dysfunction

Journal of Clinical Biochemistry and Nutrition

Volumn 56, Issue 1, 2015, Pages 35-42

  Watari, Eriko ^a   Taketani, Yutaka ^a   Kitamura, Tomoyo ^a   Tanaka, Terumi ^a   Ohminami, Hirokazu ^a   Abuduli, Maerjianghan ^a   Harada, Nagakatsu ^a   Yamanaka Okumura, Hisami ^a   Yamamoto, Hironori ^a,b   Takeda, Eiji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b JIN AI UNIVERSITY   (Japan)

Author keywords

Circadian rhythm; Dietary phosphorus; Inflammation; Oxidative stress; Phosphorus spike

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHORUS;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; FEEDING; HUMAN; IMMUNOBLOTTING; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; VASODILATATION;

RATTUS;

EID: 84920381350     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.14-96     Document Type: Article

References (39)

1. Poduval RD, Wolgemuth C, Ferrell J, Hammes MS. Hyperphosphatemia in dialysis patients: is there a role for focused counseling? J Ren Nutr 2003; 13: 219-233.
2. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95: 560-567.
3. Block GA, Klassen PS, Lazarus JM, Ofsthum N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintemance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218.
4. Block GA, Pork FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000; 35: 1226-1237.
5. Blown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9: 1136-1142.
6. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Pork FK. Association of elevated serum PO4,Ca × PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
7. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17.
8. Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moysés RM, Jorgetti V. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 2004; 66: 2237-2244.
9. Amann K, Törnig J, Kugel B, et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 2003; 63: 1296-1301.
10. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol And Recurrent Events Trial Investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633.
11. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885.
12. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III-27-III-32.
13. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
14. Ceriollo A. Postprandial hyperglycemia and diseases complications: is it time to treat? Diabates 2005; 54: 1-7.
15. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. J Clin Pract 2006; 60: 308-314.
16. Valeri C, Pozzilli P, Leslie D. Glucose control in diabetes. Diabates Metab Res Rev 2004; 20 (Suppl 2): S1-S8.
17. Azuma K, Watada H, Niihashi M, et al. A new En face method is useful to quantitate endothelial damage in vivo. Biochem Biophys Res Commun 2003; 309: 384-390.
18. Azuma K, Kawamori R, Toyofuku Y, et al. Repetitive fluctuation in blood glucose enhance monocyte adhension to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006; 26: 2275-2280.
19. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 2795-2804.
20. Takeda E, Taketani Y, Nashiki K, et al. A novel function of phosphatemediated intracellular signal transdunction pathways. Adv Enzyme Regul 2006; 46: 154-161.
21. Shuto E, Taketani Y, Tanaka R, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009; 20: 1504-1512.
22. DiMarco GS, Hausberg M, Hillebrand U, et al. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. Am J Physiol Renal Physiol 2008; 294: F1381-F1387.
23. Portale AA, Halloran BP, Morris RC Jr. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. J Clin Invest 1987; 83: 1147-1154.
24. Roberto M, Bellizzi V, Cioffi M, et al. Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol 2002; 13: 1046-1054.
25. Katai K, Segawa H, Haga H, et al. Acute regulation by dietary phosphate of the sodium-dependent phosphate transporter (NaP(i)-2) in rat kidney. J Biochem 1997; 121: 50-55.
26. Harada N, Sakamoto S, Niwa Y, Nakaya Y. Involvement of adenosine in vascular constractile preconditioning. Am J Physiol Heart Circ Physiol 2001; 280: H2911-H2919.
27. Vu Van T, Watari E, Taketani Y, et al. Dietary phosphate restriction ameliorates endothelial dysfunctin in adenine-induced kidney disease rats. J Clin Biochem Nutr 2012; 51: 27-32.
28. Sato K, Arai H, Mizuno A, et al. Dietary palatinose and oleic acid wameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. J Nutr 2007; 137: 1908-1915.
29. Takeda E, Yamamoto H, Nashiki K, Sato T, Arai H, Taketani Y. Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med 2004; 8: 191-200.
30. Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y. Dietary phosphorus in bone health and quality of life. Nutr Rev 2012; 70: 311-321.
31. Baykan M, Erem C, Erdogan T, et al. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 2007; 23: 323-328.
32. Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94: 3849-3856.
33. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408.
34. Codoñer-Franch P, Travárez-Alonso S, Simó-Jordá R, Laporta-Martin P, Carratala-Calvo A, Alonso-Iglesias E. Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J Pediatr 2012; 161: 848-854.
35. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322.
36. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.
37. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349.
38. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96: E830-E835.
39. Yiu YF, Yiu KH, Siu CW, et al. Randomized controlled trial of vitamin D supplementation on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013; 227: 140-146.